Synchrony Financial (SYF) stock is currently trading at a notable discount relative to the Zacks Financial Miscellaneous Servicesindustry. With a forward 12-month price-to-earnings (P/E) ratio of 10.26, it sits well below the industry average of 16.18. The company has a Value Score of A.Image Source: Zacks Investment ResearchIn comparison, companies like Bread Financial Holdings, Inc. (BFH) and StoneX Group Inc. (SNEX) are trading at a P/E ratio of 9.31 and 12.94, respectively. Given SYF’s valuation, we nee ...

Synchrony Financial and Apple Pay Integration - Synchrony Financial has enabled the Pay Later feature of Apple Pay for eligible Synchrony Preferred Mastercard, Synchrony Plus World Mastercard, and Synchrony Premier World Mastercard holders, offering flexibility in payment options [1] - Cardholders must add their Synchrony Mastercard to Apple Wallet to use Apple Pay, and during checkout, they can select the Pay Later option to view promotional offers [2] - Apple Pay ensures a secure and private payment experience, as transaction details remain confidential and are not stored by Apple [3] Expansion Plans and Customer Benefits - Synchrony plans to extend the fixed monthly payment option to a broader range of Apple Pay users and will allow customers to view and redeem rewards during checkout later this year [4] - The move aims to provide greater choice and flexibility at checkout, potentially boosting consumer purchasing power by offering financing solutions that avoid lump-sum payments [5] Financial Impact and Growth Potential - The integration of simplified digital transactions and diversified credit needs is expected to attract new customers and retain existing ones, potentially increasing Synchrony's loan interest and fees, which grew by 10.5% year-over-year in the first nine months of 2024 [6] - Synchrony's digital and analytics expertise, supported by acquisitions, partnerships, and tech investments, has strengthened its position and secured agreements with leading retailers and manufacturers [7] Share Price Performance and Industry Comparison - Synchrony's shares have gained 89.6% in the past year, significantly outperforming the industry's 24.5% growth [8] - The company currently holds a Zacks Rank 3 (Hold) [8] Other Finance Stocks to Consider - Intercorp Financial Services (IFS) has a Zacks Rank 1 (Strong Buy) and has seen its 2025 earnings estimate improve by 48.2% from 2024, with revenue growth expected at 9% [10] - Ameriprise Financial (AMP) holds a Zacks Rank 2 (Buy) and has a 2025 earnings estimate improvement of 14.6% from 2024, with revenue growth projected at 7.6% [11] - Civista Bancshares (CIVB) also holds a Zacks Rank 2 (Buy) and has a 2025 earnings estimate improvement of 8.2% from 2024, with revenue growth expected at 6.4% [12] - Shares of Intercorp Financial Services, Ameriprise Financial, and Civista Bancshares have gained 28.2%, 45.8%, and 21.8%, respectively, in the past year [13]

Synchrony Financial (SYF) recently announced its partnership with Pet Paradise, a pet care provider, to expand access to a plethora of care for pets. Through this partnership, SYF’s CareCredit health and wellness credit card can be used to pay for services like day camp packages, dog training, and extended boarding stays at 60 Pet Paradise locations by 2025-end.With this partnership, SYF is solidifying its position as the preferred financing solution for pet parents by expanding its reach with Pet Paradise. ...

CareCredit can be used to pay for services from dog training to vet care at Pet Paradise resorts.STAMFORD, Conn., Jan. 15, 2025 /PRNewswire/ -- Synchrony (NYSE: SYF), a leading consumer financial services company, and Pet Paradise, a premium pet care provider, today announced a new partnership designed to make access to an assortment of care easier for pet parents.  By the end of year, the CareCredit health and wellness credit card will be available to be used at all 60 Pet Paradise locations nationwide to ...

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Synchrony (SYF) , which belongs to the Zacks Financial - Miscellaneous Services industry, could be a great candidate to consider.This consumer credit company has an established record of topping earnings estimates, especially when looking at the previous two reports. The company boasts an average surprise for the past two quarters of 12.21%.For the las ...

STAMFORD, Conn., Jan. 7, 2025 /PRNewswire/ -- Synchrony (NYSE: SYF) plans to report its fourth quarter 2024 results on Tuesday, January 28, 2025. The earnings release and presentation materials are scheduled to be released and posted to the Investor Relations section of the Company's website, www.investors.synchrony.com, at approximately 6:00 a.m. Eastern Time.  A conference call to discuss Synchrony's results will be held at 8:00 a.m. Eastern Time on that day; the live audio webcast and replay can be acces ...

I have always been interested in the financial sector. But up until a couple of years ago, I only dipped my toes in it slightly. Over time, I have gotten much more comfortable with the industry and, while I do believe that it has certainCrude Value Insights offers you an investing service and community focused on oil and natural gas. We focus on cash flow and the companies that generate it, leading to value and growth prospects with real potential.Subscribers get to use a 50+ stock model account, in-depth c ...

Synchrony Continues as Exclusive Issuer of the Techron Advantage Credit Card for Chevron and Texaco Customers STAMFORD, Conn., Dec. 18, 2024 /PRNewswire/ -- Synchrony (NYSE: SYF), a premier consumer financial services company, today announced the extension of their collaboration with Chevron U.S.A. Inc., a wholly owned subsidiary of Chevron Corporation (NYSE: CVX), on the Techron Advantage Credit Card program. The amendment by the parties of their existing agreement to extend the term builds upon the succes ...

Partnership Overview - Synchrony Financial (SYF) announced a three-year partnership with Daybreak, a provider of at-home sleep health solutions, allowing customers to use Synchrony's CareCredit card for flexible financing of Daybreak's FDA-cleared sleep apnea devices and diagnostic kits [1] - The partnership aligns with Synchrony's strategy to expand its health and wellness offerings, tapping into a growing market that prioritizes sleep health as a foundation for overall well-being [3] Market Opportunity - Sleep disorders affect approximately 50-70 million Americans, creating a significant market opportunity for accessible and cost-effective solutions [2] - Traditional in-lab sleep studies often involve high out-of-pocket expenses, making Daybreak's at-home solutions combined with CareCredit financing a more accessible option for consumers [2] Financial Impact - Health and Wellness accounted for 17.3% of Synchrony's total interest and fees on loans in Q3 2024 [4] - The partnership is expected to aid Synchrony in increasing period-end loan receivables and interest and fees on loans, especially as the Health and Wellness segment's purchase volumes declined 3% year-over-year in Q3 2024 [5] Stock Performance - Synchrony's shares have gained 56.9% in the past six months, outperforming the industry's 22.5% growth [6] Industry Context - Synchrony currently holds a Zacks Rank 1 (Strong Buy), indicating strong market confidence in its performance [7] - Other top-ranked stocks in the finance space include ProAssurance Corporation (PRA), Kemper Corporation (KMPR), and CNO Financial Group, Inc (CNO), with PRA also holding a Zacks Rank 1 and KMPR and CNO carrying a Zacks Rank 2 (Buy) [7]

CareCredit health and wellness credit card now accepted as a payment option for Daybreak's sleep testing-kits and sleep apnea deviceSTAMFORD, Conn., Dec. 3, 2024 /PRNewswire/ -- Synchrony (NYSE: SYF), a premier consumer financial services company, and Daybreak, a top-provider of full at-home sleep testing kits and custom-fit sleep apnea devices, have extended flexible financing to customers interested in Daybreak's products. With an estimated 50-70 million Americans currently living with ongoing sleep disor ...